Cambridge Industries' mandamus petition gave the Federal Circuit another 2025 vehicle for PTAB discretionary-denial practice.
The order arose from IPR petitions filed against several patents while PTO guidance addressed how parallel district-court litigation and stipulations should affect institution.
The merits of patentability were not the main event. The operational issue was whether a petitioner could obtain extraordinary appellate intervention when institution practice changed the path of review.
For PTAB users, the case belongs in a policy ledger that separates final written decisions from front-end institution risk.